PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514969
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514969
Asia Pacific Intraoperative Neuromonitoring Market was valued at USD 667.23 million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.
Intraoperative neurophysiological monitoring (IONM) is a valuable tool in enhancing the safety of high-risk neurosurgical procedures. It encompasses a range of techniques utilized during surgery to monitor neural pathways in neurosurgical, orthopedic, peripheral nerve, and vascular surgeries. These techniques aid in preventing damage and preserving the functionality of the nervous system. Intraoperative neurophysiological monitoring has been employed to minimize neurological morbidity resulting from surgical manipulations. Additionally, it has proven effective in identifying anatomical structures, such as peripheral nerves and sensorimotor cortex, to assist surgeons during dissection.
Asia Pacific Intraoperative Neuromonitoring Market- Market Dynamics
Increasing emphasis on patient safety during difficult surgical procedures and the growing prevalence of chronic disorders are expected to drive the growth of the market
There is a rising awareness of the significance of patient safety in intricate surgical procedures. Intraoperative neuromonitoring (IONM) plays a vital role in monitoring neural pathways and detecting potential risks to nerve function in real time. Urological procedures account for 20.5 million surgeries, with BPH surgeries being the most common in China due to gender imbalances. With demographic changes and an ageing population in the Asia Pacific region, there is a higher prevalence of chronic diseases requiring surgical treatment. According to the National Center for Biotechnology Information, the national prevalence of chronic diseases in China's older adults is 81.1%. Advancements in neuromonitoring technologies and healthcare infrastructure investments in the Asia Pacific region present growth opportunities for the market. However, regulatory complexities may pose challenges to market growth.
Asia Pacific Intraoperative Neuromonitoring Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)
Based on Source Type segmentation, Insourced monitoring was the leading type in 2023
Based on Modality segmentation, Electromyography (EMG) was the leading type in 2023
Based on Application segmentation, Spinal surgery was the leading type in 2023
Based on End-User segmentation, the hospital was the leading type in 2023
Based on countries, China was the leading revenue generator in 2023
The Asia Pacific Intraoperative Neuromonitoring Market is segmented based on Product and Service, Source Type, Modality, Application, End-User, and Country.
The market is segmented into three distinct categories according to Product and Service: Systems, Accessories, and Services. All three of these categories play a crucial role in the successful integration and effectiveness of neuromonitoring during surgical procedures.
The market is categorized into two groups according to Source Type: Insourced monitoring and outsourced monitoring. Insourced monitoring holds the majority share in the market. In the Asia Pacific IONM market, insourced monitoring is favored by hospitals aiming to improve patient care and surgical results, all while controlling costs and service delivery.
The market is divided into six segments based on Modality: Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem auditory evoked potentials (BAEPs), and Visual evoked potentials (VEPs). Electromyography (EMG) dominates the market share. Intraoperative Neuromonitoring (IONM) that utilizes Electromyography (EMG) is a crucial sector within the broader IONM market. EMG serves as a vital technique for monitoring the electrical activity of muscles and nerves during surgical procedures.
The market is divided into four segments based on its application: Spinal surgery, Neurosurgery, Orthopedic surgery, ENT surgery, vascular surgery, and others. The majority share in the market is held by Spinal surgery. Intraoperative Neuromonitoring (IONM) is essential in ensuring patient safety and achieving the best surgical results, particularly in spinal surgery. The use of IONM in spinal surgeries provides real-time feedback to the surgical team and helps in preventing nerve damage.
The market is divided into two segments based on the end-user: hospitals and ambulatory surgery centers. The hospital sector is the leading force in the market. Numerous hospitals provide specialized neuromonitoring services for different surgical specialties, such as neurosurgery, orthopedic surgery (such as spine surgery), ENT surgery, and vascular surgery. Each specialty may necessitate specific IONM modalities customized to the surgical procedure.
Asia Pacific Intraoperative Neuromonitoring Market- Geographical Insights
The analysis of the Asia Pacific Intraoperative Neuromonitoring market includes countries such as India, China, South Korea, Japan, Australia, Thailand, Indonesia, and the Philippines, along with the rest of the Asia Pacific (APAC) region. China is at the forefront of the Intraoperative Neuromonitoring Market in terms of market share, due to its growing emphasis on research and development efforts. Chinese healthcare establishments and technology companies are placing a greater emphasis on research and development (R&D) to enhance and advance neuromonitoring technologies.
In the Asia Pacific Intraoperative Neuromonitoring market, major players employ various strategic approaches to maintain a competitive edge. Established companies leverage their wide market presence and distribution networks across the Asia Pacific region, forging partnerships with hospitals, surgical centers, and healthcare providers to expand their business and enhance service quality. Investments in these areas aim to enhance user satisfaction and operational efficiency. Competitors often utilize tactics such as geographical expansion, mergers and acquisitions, and partnerships with research institutions or healthcare organizations to strengthen their market position and capitalize on new prospects.
Nihon Kohden, a leading company in the field of medical electronic equipment globally, is pleased to announce the introduction of the One View solution as an innovative feature in the Neuromaster G1 intraoperative neuromonitoring (IONM) system. This advanced solution facilitates the seamless integration of the patient's anesthesia and vital signs, including heart rate, SpO2, temperature, and more, with neurological data within the IONM software.
On October 29, 2020, Medtronic plc, a leading global medical technology company, revealed that it has obtained clearance from the U.S. Food and Drug Administration (FDA) for its NIM Vital nerve monitoring system. This innovative system allows doctors to detect, confirm, and monitor nerve function, thereby minimizing the potential for nerve damage during head and neck surgeries.
ASIA PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Nihon Kohden Corporation
Inomed Medizintechnik GmbH
Medtronic PLC
SpecialtyCare, Inc. (Morgan Stanley)
NeuroStyle Pte. Ltd.
Computational Diagnostics, Inc.
Accurate Neuromonitoring, LLC (Housatonic Partners)
Intranerve Neuroscience Holdings, Llc
Natus Medical Incorporated (Archimed SAS)
Others
ASIA PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCT AND SERVICE - MARKET ANALYSIS, 2019 - 2032
Systems
Accessories
Services
ASIA PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE- MARKET ANALYSIS, 2019 - 2032
Insourced Monitoring
Outsourced Monitoring
ASIA PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY - MARKET ANALYSIS, 2019 - 2032
Motor Evoked Potentials (MEPs)
Somatosensory Evoked Potentials (SSEPs)
Electroencephalography (EEG)
Electromyography (EMG)
Brainstem Auditory Evoked Potentials (BAEPs)
Visual Evoked Potentials (VEPs)
ASIA PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
Spinal Surgery
Neurosurgery
Orthopedic Surgery
ENT Surgery
Vascular Surgery
Other
ASIA PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032
Hospital
Ambulatory Surgery Center
ASIA PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY- MARKET ANALYSIS, 2019 - 2032
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC